Cargando…

Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck

The proteins sodium iodide symporter (NIS), μ-crystallin (CRYM), and thyroid hormone receptor beta (THRB) have been associated with prognosis in various cancer entities. While NIS and THRB may serve as possible therapeutic targets, the role of CRYM in cancer is still unclear. Protein levels of 44 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schnoell, Julia, Kotowski, Ulana, Jank, Bernhard J., Stoiber, Stefan, Gurnhofer, Elisabeth, Schlederer, Michaela, Heiduschka, Gregor, Kenner, Lukas, Kadletz-Wanke, Lorenz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703850/ https://www.ncbi.nlm.nih.gov/pubmed/34945824 http://dx.doi.org/10.3390/jpm11121352

Ejemplares similares

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2022)

µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
por: Jank, Bernhard J., et al.
Publicado: (2021)

Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort
por: Schnoell, Julia, et al.
Publicado: (2020)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival
por: Schnoell, Julia, et al.
Publicado: (2020)

β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)

AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck
por: Kadletz, Lorenz C., et al.
Publicado: (2019)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

The Potential Prognostic Value of a Novel Hematologic Marker Fibrinogen-to-Lymphocyte Ratio in Head and Neck Adenoid-Cystic Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro
por: Maier, Tobias, et al.
Publicado: (2022)

High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
por: Scheiflinger, Alexandra, et al.
Publicado: (2023)

Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma
por: Friedl, Marlene, et al.
Publicado: (2022)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer
por: Spielvogel, Clemens P., et al.
Publicado: (2022)

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro
por: Jank, Bernhard J., et al.
Publicado: (2022)

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)

The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer
por: Haas, Markus, et al.
Publicado: (2023)

Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab
por: Haas, Markus, et al.
Publicado: (2023)

The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines
por: Haas, Markus, et al.
Publicado: (2022)

Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

Evaluation of the External Jugular Vein Overlying the Sternocleidomastoid Muscle as Venous Lymph-Node Flap
por: Kadletz-Wanke, Lorenz, et al.
Publicado: (2022)

ELMO3 – a Negative Prognostic Marker in Minor Salivary Gland Carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2018)

Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage
por: Thierauf, Julia, et al.
Publicado: (2018)

Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study
por: Jank, Bernhard J., et al.
Publicado: (2019)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

In vitro antineoplastic effects of MK0752 in HPV-positive head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Mcl-1 Expression Is Up-Regulated in Malignancies of the Parotid Gland
por: Heiduschka, Gregor, et al.
Publicado: (2011)

Rare location of head and neck adenoid cystic carcinoma
por: Naim, Asmaa, et al.
Publicado: (2019)

Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck
por: Rodriguez-Russo, Carlos A., et al.
Publicado: (2021)

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck
por: Doescher, Johannes, et al.
Publicado: (2022)

Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
por: Choi, Seo Hee, et al.
Publicado: (2022)

Adenoid cystic carcinoma of head and neck: Summary and review of imaging findings
por: Wang, Yidan, et al.
Publicado: (2023)

AKT3 drives adenoid cystic carcinoma development in salivary glands
por: Zboray, Katalin, et al.
Publicado: (2017)

The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication
por: Dou, Shengjin, et al.
Publicado: (2021)

The Role of Particle Therapy in Adenoid Cystic Carcinoma and Mucosal Melanoma of the Head and Neck
por: Ebner, Daniel K., et al.
Publicado: (2021)

Adenoid cystic carcinoma of palate
por: Mehta, Dhaval N., et al.
Publicado: (2013)

Dedifferentiation in adenoid cystic carcinoma
por: Bavle, Radhika M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sdh16mdnmkmtjmshp91qb4jgvk